Stem-Cell Therapy Misses Mark in Lymphoma Trial (CME/CE)

(MedPage Today) -- Progression of aggressive non-Hodgkin's lymphoma slowed significantly after autologous stem-cell transplantation, although overall survival did not improve, according to results of a randomized trial.
Source: MedPage Today Hematology/Oncology - Category: Hematology Source Type: news